{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.194","meta":{"versionId":"13","lastUpdated":"2021-05-21T01:00:57.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.194","version":"20210521","name":"Pertuzumab Injectable","status":"active","date":"2021-05-21T01:00:57-04:00","publisher":"American Society of Clinical Oncology Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1298948","display":"14 ML pertuzumab 30 MG/ML Injection"}]}]},"expansion":{"identifier":"urn:uuid:b3e387ce-636d-4b64-ad7a-6600e40230a4","timestamp":"2022-06-10T10:52:29-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"1298948","display":"14 ML pertuzumab 30 MG/ML Injection"}]}}